文献速递腹部MR

分数阶微积分扩散MRI模型无创评估胃腺癌Lauren分型

In vivo assessment of Lauren classification for gastric adenocarcinoma using diffusion MRI with a fractional order calculus model.
PubMed 文献 · Eur Radiol · 2021-02-22

本研究纳入43例胃腺癌患者(女15例、男28例),在1.5 T MRI上采用11个b值(0–2000 s/mm²)采集扩散加权图像,评估分数阶微积分(FROC)模型参数D、β、μ及常规ADC对弥漫及混合型与肠型胃腺癌的鉴别能力。结果显示两组间D、β、μ及ADC差异均有统计学意义,μ的AUC最大(0.739),(D、β、μ)及(β、μ)组合表现最佳,敏感度0.739、特异度0.750、准确率0.744、AUC 0.793(95%CI 0.657–0.929)。作者认为FROC模型扩散MRI有望用于胃腺癌Lauren分型的无创评估。

要点

  • FROC模型参数μ单独鉴别弥漫及混合型与肠型的AUC最大,为0.739。
  • (D、β、μ)或(β、μ)组合鉴别两组的最佳AUC为0.793(95%CI 0.657–0.929)。
  • 弥漫及混合型的D、β、μ及ADC均值均低于肠型,差异有统计学意义。

关键影像表现/征象

  • 弥漫及混合型病灶的D均值为0.99 ± 0.20 μm²/ms,低于肠型的1.11 ± 0.23 μm²/ms(p = 0.036)。
  • 弥漫及混合型病灶的β均值为0.37 ± 0.08,低于肠型的0.43 ± 0.11(p = 0.043)。
  • 弥漫及混合型病灶的μ均值为7.92 ± 2.79 μm,低于肠型的9.87 ± 1.52 μm(p = 0.038)。
  • 弥漫及混合型病灶的ADC均值为0.81 ± 0.34 μm²/ms,低于肠型的0.96 ± 0.19 μm²/ms(p = 0.033)。

诊断标准与关键数值

  • 单个参数中μ的ROC曲线下面积最大,为0.739。
  • (D、β、μ)及(β、μ)组合鉴别弥漫及混合型与肠型表现最佳,敏感度0.739、特异度0.750、准确率0.744、AUC 0.793(95%CI 0.657–0.929)。

临床应用与阅片要点

  • 可采用FROC模型参数D、β、μ及常规ADC辅助鉴别胃腺癌弥漫及混合型与肠型。
  • 作者认为FROC模型参数单独或联合应用有望在疾病进展或缓解过程中多次无创评估以补充常规Lauren分型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the performance of a fractional order calculus (FROC) diffusion model for imaging-based assessment of Lauren classification in gastric adenocarcinoma.

METHODS: In this study, 43 patients (15 females, 28 males) with gastric adenocarcinoma underwent MRI at 1.5 T. According to pathology-based Lauren classification, 10 patients had diffuse-type, 20 had intestinal-type, and 13 had mixed-type lesions. The diffuse and mixed types were combined as diffuse-and-mixed type to be differentiated from the intestinal type using diffusion MRI. Diffusion-weighted images were acquired by using eleven b-values (0-2000 s/mm2). Three FROC model parameters comprising diffusion coefficient D, intravoxel diffusion heterogeneity β, and a microstructural quantity μ, together with a conventional apparent diffusion coefficient (ADC), were estimated. The mean parameter values in the tumour were computed by using a percentile histogram analysis. Individual or linear combinations of the mean parameters in the tumour were used to differentiate the diffuse-and-mixed type from the intestinal type using descriptive statistics and receiver operating characteristic (ROC) analyses.

RESULTS: Significant differences were observed between diffuse-and-mixed-type and intestinal-type lesions in D (0.99 ± 0.20 μm2/ms vs. 1.11 ± 0.23 μm2/ms; p = 0.036), β (0.37 ± 0.08 vs. 0.43 ± 0.11; p = 0.043), μ (7.92 ± 2.79 μm vs. 9.87 ± 1.52 μm; p = 0.038), and ADC (0.81 ± 0.34 μm2/ms vs. 0.96 ± 0.19 μm2/ms; p = 0.033). Among the individual parameters, μ produced the largest area under the ROC curve (0.739). The combinations of (D, β, μ) and (β and μ) produced the best overall performance with a sensitivity of 0.739, specificity of 0.750, accuracy of 0.744, and area under the curve of 0.793 (95% confidence interval: 0.657-0.929).

CONCLUSION: Diffusion MRI with the FROC model holds promise for non-invasive assessment of Lauren classification for gastric adenocarcinoma.

KEY POINTS: • High b-value diffusion MRI with a FROC model that is sensitive to tissue microstructures can differentiate the diffuse-and-mixed type from intestinal type of gastric adenocarcinoma. • The combination of FROC parameters produced the best result for distinguishing the diffuse-and-mixed type from the intestinal type with an area under the receiver operating characteristic curve of 0.793. • The FROC model parameters, individually or conjointly, hold promise for repeated, non-invasive evaluations of gastric adenocarcinoma at various time points throughout disease progression or regression to complement conventional Lauren classification.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Karaman MM, Tang L, Li Z, et al. In vivo assessment of Lauren classification for gastric adenocarcinoma using diffusion MRI with a fractional order calculus model. Eur Radiol. 2021. PMID: 33616764. doi:10.1007/s00330-021-07694-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。